Colistics Pharmacy
(504) 361-5650
2901 General Degaulle Drive
Suite 101
New Orleans, LA 70114
(844) 230-5490
Recursos del Paciente
- Inicio
- Recursos del Paciente
- Resultados de su búsqueda
Manténgase sano!
Resultados de su búsqueda "Weight Loss".
Videos de salud - 7
Intermittent Fasting Leads to Greater Weight Loss Than Calorie Counting, New Study Finds
Overweight and obese adults who followed a 4:3 intermittent fasting plan dropped more pounds in one year than those who counted calories.
Plastic Surgery for ‘Ozempic Face’ Growing in Popularity
Hollow cheeks and sagging skin are driving more weight-loss patients to the plastic surgeon; a new survey finds.
Do Calorie Labels on Menus and Food Products Really Impact Your Diet?
A new study finds calorie labels make a small but potentially significant impact on food selection and calorie intake.
Rating the Best Diets for 2025
U.S. News & World Report, working with leading medical and nutrition experts, reveals a list of the best diets for overall health and specific conditions.
U.S. Obesity Rate Drops for the First Time in a Decade
New study examines U.S. trends in body mass index and obesity and finds improving numbers, driven in part by GLP-1 weight-loss drugs.
Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds
New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.
Taking Ozempic or Wegovy Does Not Increase Risk for Mental Health Issues, Study Finds
Researchers find no link between semaglutide, the main ingredient in Ozempic and Wegovy, and depression, suicidal thoughts or behaviors in patients with no prior history of the conditions.
Resultados de noticias de salud - 201
Fasting Outperforms Calorie Cutting, Clinical Trial Says
- Dennis Thompson HealthDay Reporter
- April 1, 2025
- Página completa
Fasting every other day can prompt more weight loss than simply cutting calories, a new clinical trial shows.
People who undertook 4:3 intermittent fasting lost just under 8% of their body weight within a year, compared to a 5% loss among people who cut their daily calor...
Novo Nordisk to Pay $2 Billion for New Weight Loss Drug
- I. Edwards HealthDay Reporter
- March 25, 2025
- Página completa
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24.
The drug, cal...
Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance
- I. Edwards HealthDay Reporter
- March 7, 2025
- Página completa
The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.
Novo Nordisk, the Danish company behind Wegovy, announ...
No Suicide Risk Associated With GLP-1 Drugs
- Dennis Thompson HealthDay Reporter
- February 28, 2025
- Página completa
GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has concluded.
Earlier research had potentially linked the...
Weight-Loss Drugs Could Help Extend Life of Replacement Joints
- Dennis Thompson HealthDay Reporter
- February 24, 2025
- Página completa
MONDAY, Feb. 24, 2025 (HealthDay news) -- Even slight weight loss spurred on by cutting-edge GLP-1 drugs can help prevent replacement knees and hips from wearing out, a new study suggests.
People with new knees and hips are significantly less likely to need follow-up sur...
Juicing Diets Can Harm Health in Just 3 Days, Study Finds
- Denise Mann HealthDay Reporter
- February 18, 2025
- Página completa
Juice cleanses are a popular way to kickstart a health journey, but these diets may do more harm than good in as little as three days.
A study published recently in the journal Nutrients found that consuming ...
More Evidence Ozempic Can Curb Alcoholism
- Ernie Mundell HealthDay Reporter
- February 12, 2025
- Página completa
Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake.
The research found that, compared to placebo, weekly injections of semaglutide (also marketed for weight loss as
Diabetic 'Yo-yo' Dieting Can Harm Kidneys
- Dennis Thompson HealthDay Reporter
- February 5, 2025
- Página completa
“Yo-yo” dieting -- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns.
Diabe...
Weight-Loss Surgery Protects Liver Health
- Dennis Thompson HealthDay Reporter
- January 30, 2025
- Página completa
Weight-loss surgery can protect the liver health of patients with obesity and fatty liver disease, a new study reports.
Patients had a 72% lower risk of developing serious complications of liver disease after undergoing weight-loss surgery, researchers reported in Jan. 2...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
- India Edwards HealthDay Reporter
- January 21, 2025
- Página completa
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even
Black Patients Less Likely To Get Weight Loss Surgery
- Dennis Thompson HealthDay Reporter
- January 21, 2025
- Página completa
Black people with obesity are less likely to get weight-loss surgery than others.
Black people are just as likely to discuss the procedure with their doctor -- nearly 10%, compared with 9% of patients of other races, researchers said.
But only about 8% of those Bla...
The New Definition of Obesity
- Dennis Thompson HealthDay Reporter
- January 14, 2025
- Página completa
The way obesity is diagnosed needs to become more sophisticated, an international commission has concluded.
Using body-mass index (BMI) to tell who is overweight or obese is not reliable, and can result in misdiagnosis, the Commission on Clinical Obesity says in a new pa...
Fitness Matters More Than Weight for Longevity, Study Says
- India Edwards HealthDay Reporter
- January 9, 2025
- Página completa
When it comes to living a longer life, staying active may matter far more than what the scale says.
Per the largest study yet on fitness, body weight, and longevity published recently in the
About 50% of Adults Resolve to Try New Diet, Survey Says
- Dennis Thompson HealthDay Reporter
- January 6, 2025
- Página completa
A new diet is on the New Year’s resolution list for nearly half of U.S. adults, according to a new survey from the Physicians Committee for Responsible Medicine.
However, many plan to pick up diets with dicey track records, survey results show.
About 46% of a...
These Are Some of the Best Diets for 2025, Report Says
- Denise Maher HealthDay Reporter
- January 3, 2025
- Página completa
Wondering which popular diet will help you shed extra weight in a healthy way this year?
The Mediterranean diet tops the best diet categories in the U.S. News & World Report 2025 edition.
According to the report, the eating style that refers to the traditional ...
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
- Denise Maher HealthDay Reporter
- December 26, 2024
- Página completa
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes.
U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose
- Ernie Mundell HealthDay Reporter
- December 13, 2024
- Página completa
The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss meds, a new study finds.
Data on almost 17 million adults natio...
GLP-1 Meds May Lower Clot Risk in People With Diabetes
- Ernie Mundell HealthDay Reporter
- December 10, 2024
- Página completa
People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds....
Weight Loss Brings Americans Big Health Care Savings
- Ernie Mundell HealthDay Reporter
- December 5, 2024
- Página completa
The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost should be covered by Medicare, Medicaid and private insure...
Zepbound Bests Wegovy for Weight Loss in New Trial
- Robin Foster HealthDay Reporter
- December 4, 2024
- Página completa
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
"Given the increased interest around obesity medications, we conducted this study to help health care providers and patie...
Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds
- Ernie Mundell HealthDay Reporter
- November 26, 2024
- Página completa
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.<...
Study Finds GLP-1 Meds Can Also Help the Kidneys
- Ernie Mundell HealthDay Reporter
- November 26, 2024
- Página completa
The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm.
In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the org...
Taking a GLP-1 Medication? Here's Tips to Holiday Eating
- Robin Foster HealthDay Reporter
- November 23, 2024
- Página completa
So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you worry about how to handle gatherings where decadent food will be served in abundance.
Luckily, one expert from Baylor College of Medicine has tips...
Meds Like Ozempic Are Causing Folks to Waste More Food
- Ernie Mundell HealthDay Reporter
- November 22, 2024
- Página completa
America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows.
Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death
- Dennis Thompson HealthDay Reporter
- November 11, 2024
- Página completa
The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says.
GLP-1 weight-loss...
Unexplained Weight Loss and What It Can Mean for Your Health
- Carole Tanzer Miller HealthDay Reporter
- November 9, 2024
- Página completa
It may seem counter-intuitive, but losing weight without even trying may not be a good thing.
"It's not typical to have a noticeable drop in weight without changing how much you're eating, being more physically active or trying to lose weight," said dietitian
Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
- Robin Foster HealthDay Reporter
- November 7, 2024
- Página completa
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least 100 hospitalizations and 10 deaths.
“Honestly, I’m quite al...
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
- Dennis Thompson HealthDay Reporter
- November 5, 2024
- Página completa
Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discov...
Ozempic, Wegovy Could Help Ease Knee Arthritis Pain
- Dennis Thompson HealthDay Reporter
- November 1, 2024
- Página completa
The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found.
People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% dec...
Ozempic Curbs Kidney Disease in Obese People Without Diabetes
- Dennis Thompson HealthDay Reporter
- October 28, 2024
- Página completa
The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows.
Patients taking semaglutide -- the active agent in Ozempic and Wegovy -- had as ...
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
- Ernie Mundell HealthDay Reporter
- October 25, 2024
- Página completa
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and...
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
- Dennis Thompson HealthDay Reporter
- October 24, 2024
- Página completa
Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.
People with type 2 diabetes taking semaglutide appeared to have a significantly...
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year
- Dennis Thompson HealthDay Reporter
- October 24, 2024
- Página completa
Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 deaths a year...
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
- Robin Foster HealthDay Reporter
- October 15, 2024
- Página completa
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.
GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It
- HealthDay Reporter
- October 14, 2024
- Página completa
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.
But a new study involving more than 54,000 U.S. adolescents found no such...
Ozempic Plus Intestinal 'Zap' Therapy May Eliminate Need for Insulin in Type 2 Diabetics
- Ernie Mundell HealthDay Reporter
- October 14, 2024
- Página completa
Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with type 2 diabetes.
The new trial hasn't yet been published in a peer-reviewed journal and...
Could Certain Genes Help You Slim Down?
- Dennis Thompson HealthDay Reporter
- October 11, 2024
- Página completa
The key to weight loss could come down to a combination of 14 “skinny genes,” a recent study says.
People with these genes dropped twice as much weight through regular exercise compared to those without the genes, researchers found.
Those with the most ...
Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds for Employees
- Robin Foster HealthDay Reporter
- October 9, 2024
- Página completa
When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health insurance plans, a new survey shows.
GLP-1 Weight-Loss Meds Could Interfere With Endoscopy, Colonoscopy
- Ernie Mundell HealthDay Reporter
- October 1, 2024
- Página completa
Food left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy.
Now, research finds this scenario is more lik...
Could Ozempic Help Prevent Opioid Overdoses?
- Dennis Thompson HealthDay Reporter
- September 25, 2024
- Página completa
In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose.
...
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
- Robin Foster HealthDay Reporter
- September 25, 2024
- Página completa
During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its block...
Endurance Exercise Can Get Rid of Body Fat, Even Without Weight Loss
- Dennis Thompson HealthDay Reporter
- September 20, 2024
- Página completa
Heavy-duty endurance exercise can cause body fat levels to drop without any accompanying weight loss, a new small-scale study indicates.
A group of eleven middle-aged men who cycled 710 miles in seven days lost only about 1% of their total weight, because they ate and dr...
Cost Has Many Going Around Doctors to Get Weight-Loss Meds
- Dennis Thompson HealthDay Reporter
- September 18, 2024
- Página completa
Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.
They’re in short supply, and often too expensive to afford without insurance cover...
Ozempic Could Curb Progression of Diabetes-Linked Liver Disease
- Ernie Mundell HealthDay Reporter
- September 16, 2024
- Página completa
Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.
In a new decades-long study, veterans with diabetes...
Ozempic or Saxenda for Weight Loss: Which Works Best?
- Dennis Thompson HealthDay Reporter
- September 13, 2024
- Página completa
Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds.<...
Ozempic, Mounjaro Help People With Type 1 Diabetes Control Blood Sugar, Lose Weight
- Dennis Thompson HealthDay Reporter
- September 13, 2024
- Página completa
Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a n...
In Every U.S. State, at Least 1 in 5 People Is Now Obese
- Ernie Mundell HealthDay Reporter
- September 12, 2024
- Página completa
Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows.
In 2013, not one state had an adult obesity rate topping 35%, but 10 years later 23 states had achieved that dubious distin...
Weight-Loss Drug Zepbound May Work Better in Women Than Men
- Dennis Thompson HealthDay Reporter
- September 12, 2024
- Página completa
The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval.
All doses of tirzepatide consistently reduced weight in...
Ozempic Can Prevent Heart Trouble in Folks With Kidney Issues
- Dennis Thompson HealthDay Reporter
- September 12, 2024
- Página completa
Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows.
The drugs’ a...
Weight-Loss Pill Saxenda Helps Kids as Young as 6
- Robin Foster HealthDay Reporter
- September 11, 2024
- Página completa
The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report.
The findings, published Tuesday in the New England Journal of Medicine and...